MASSI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 26.179
EU - Europa 18.980
AS - Asia 10.185
SA - Sud America 1.509
OC - Oceania 324
AF - Africa 291
Continente sconosciuto - Info sul continente non disponibili 10
Totale 57.478
Nazione #
US - Stati Uniti d'America 25.990
RU - Federazione Russa 6.339
PL - Polonia 4.773
SG - Singapore 2.765
CN - Cina 2.381
HK - Hong Kong 2.005
IT - Italia 1.992
IE - Irlanda 1.566
BR - Brasile 1.292
SE - Svezia 1.233
KR - Corea 1.223
DE - Germania 779
UA - Ucraina 669
FI - Finlandia 486
GB - Regno Unito 481
IN - India 429
VN - Vietnam 392
AU - Australia 317
FR - Francia 222
JO - Giordania 197
ID - Indonesia 175
TR - Turchia 167
CA - Canada 115
NL - Olanda 108
CH - Svizzera 100
AR - Argentina 80
CI - Costa d'Avorio 74
ES - Italia 66
JP - Giappone 60
PH - Filippine 51
EC - Ecuador 46
MX - Messico 46
BD - Bangladesh 43
MA - Marocco 42
ZA - Sudafrica 41
TH - Thailandia 37
IR - Iran 36
BE - Belgio 34
PK - Pakistan 26
IQ - Iraq 25
TW - Taiwan 25
AT - Austria 22
CO - Colombia 22
BJ - Benin 21
MY - Malesia 21
PE - Perù 19
EG - Egitto 18
UZ - Uzbekistan 17
KE - Kenya 16
SC - Seychelles 15
TZ - Tanzania 15
CL - Cile 14
LT - Lituania 14
PY - Paraguay 14
RO - Romania 14
DZ - Algeria 13
KZ - Kazakistan 13
CZ - Repubblica Ceca 12
DK - Danimarca 12
VE - Venezuela 12
NP - Nepal 11
SA - Arabia Saudita 11
OM - Oman 10
UG - Uganda 10
IL - Israele 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
EU - Europa 8
AL - Albania 7
NG - Nigeria 7
NZ - Nuova Zelanda 7
TN - Tunisia 7
BA - Bosnia-Erzegovina 6
BG - Bulgaria 6
GR - Grecia 6
KW - Kuwait 6
NO - Norvegia 6
PT - Portogallo 6
AZ - Azerbaigian 5
BH - Bahrain 5
CR - Costa Rica 5
PA - Panama 5
TL - Timor Orientale 5
BO - Bolivia 4
HN - Honduras 4
KG - Kirghizistan 4
UY - Uruguay 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
GE - Georgia 3
HR - Croazia 3
JM - Giamaica 3
LK - Sri Lanka 3
LV - Lettonia 3
SN - Senegal 3
GH - Ghana 2
GY - Guiana 2
HU - Ungheria 2
MK - Macedonia 2
Totale 57.447
Città #
Santa Clara 4.995
Warsaw 4.764
Fairfield 2.860
Ashburn 2.040
Singapore 1.782
Hong Kong 1.640
Dublin 1.560
Chandler 1.517
Woodbridge 1.350
Seattle 1.231
Seoul 1.198
Cambridge 1.176
Jacksonville 1.094
Houston 1.093
Wilmington 1.009
Hefei 819
Beijing 561
Lawrence 501
Ann Arbor 491
Altamura 489
Princeton 428
Buffalo 354
Los Angeles 310
Melbourne 298
Boston 294
Moscow 265
Boardman 263
Mumbai 258
Florence 253
Medford 200
Munich 182
San Diego 173
Dallas 164
New York 135
Jakarta 126
Ho Chi Minh City 119
Kent 118
Izmir 117
Milan 107
Shanghai 107
Paris 105
Bern 98
Rome 97
São Paulo 94
Norwalk 80
Dong Ket 78
Turku 75
Abidjan 74
West Jordan 74
Clifton 71
Redondo Beach 69
Bremen 66
Hanoi 66
London 55
Helsinki 53
Phoenix 48
Hillsboro 46
Toronto 46
Chicago 44
Falls Church 42
Bengaluru 41
Rio de Janeiro 41
Tokyo 40
Yubileyny 40
Barcelona 39
Frankfurt am Main 39
Lappeenranta 39
Andover 33
Curitiba 33
Verona 33
Auburn Hills 32
Montreal 31
Brussels 29
Brooklyn 28
Naples 28
Pune 28
Chennai 27
Stockholm 26
Frankfurt Am Main 25
The Dalles 25
Tianjin 25
Atlanta 24
Belo Horizonte 24
Turin 22
Cotonou 21
Manchester 21
Guayaquil 20
Johannesburg 20
Casablanca 19
Washington 19
Blackburn 18
Bologna 18
Brasília 18
Florianópolis 18
Bangkok 17
Poplar 17
San Jose 17
Scandicci 17
Charlotte 16
Saint Petersburg 16
Totale 38.866
Nome #
Formalin safety in anatomic pathology workflow and integrated air monitoring systems for the formaldehyde occupational exposure assessment 708
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 421
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 354
Droplet digital PCR (ddPCR) vs quantitative real-time PCR (qPCR) approach for detection and quantification of Merkel cell polyomavirus (MCPyV) DNA in formalin fixed paraffin embedded (FFPE) cutaneous biopsies 303
Hapten-Specific TH17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP. 300
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 299
Tattoo-Associated Skin Reaction: The Importance of an Early Diagnosis and Proper Treatment 296
Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection. 291
Multiparametric analysis of cell-free DNA in melanoma patients. 290
BRAF/NRAS Mutation Frequencies among Primary Tumors and Metastases in Patients with Melanoma 289
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 275
Discrepant alterations in main candidate genes among multiple primary melanomas 271
Transient Receptor Potential Vanilloid 4 (TRPV4) is Down-Regulated in Keratinocytes in Human Non-Melanoma Skin Cancer. 265
Impact of low-thermal-injury devices on margin status in laryngeal cancer. An experimental ex vivo study 265
Efficacy of treatment with oral alitretinoin in patient suffering from lichen simplex chronicus and severe atopic dermatitis of hands 263
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 260
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 260
Expression of protease-activated receptor-1 and-2 in orofacial granulomatosis 257
Integrated Akt/PKB Signaling in Immunomodulation and Its Potential Role in Cancer Immunotherapy 255
Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma 254
SPECIFIC IMMUNE THERAPY-RELATED CUTANEOUS b-CELL PSEUDOLYMPHOMA WITH FOLLOWING DISSEMINATION 251
Molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft versus host disease. 247
Interactive atlas of dermatoscopy. Dermoscopy: a tutorial. 242
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 241
Tissue prognostic biomarkers in primary cutaneous melanoma. 240
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. 239
KIT genetic alterations in anorectal melanomas. 239
Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities 237
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients 235
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. 234
Nras in melanoma: Targeting the undruggable target 231
Immunomodulating property of MAPK inhibitors: From translational knowledge to clinical implementation 231
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma. 231
A Critical Reappraisal of Primary and Recurrent Advanced Laryngeal Cancer Staging 231
Increase in FOXP3(+) Regulatory T Cells in GVHD Skin Biopsies Is Associated with Lower Disease Severity and Treatment Response 229
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP. 229
The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study 209
Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. 205
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors. 205
Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study 200
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 199
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 194
X-linked ichthyosis in a patient with congenital hypothyroidism 190
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center 189
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 188
A study on the placenta in stillbirth: an evaluation of molecular alterations through next generation sequencing 183
Nevi and Breslow thickness in melanoma: sex differences? 183
AKT-ions with a TWIST between EMT and MET 181
Fluorescence-advanced videodermatoscopy: A promising and potential technique for the in vivo evaluation of vitiligo 181
ANGIOKERATOMA CORPORIS DIFFUSUM (ANDERSON FABRY'S DISEASE): A CASE REPORT 179
Recognition of Cutaneous Melanoma on Digitized Histopathological Slides via Artificial Intelligence Algorithm 179
EXPRESSION OF THE RETINOBLASTOMA-RELATED GENE RB2/P130 CORRELATES WITH CLINICAL OUTCOME IN ENDOMETRIAL CANCER 177
Trpa1 expression in synovial sarcoma may support neural origin 174
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 174
Detection of Merkel cell polyomavirus and human papillomavirus DNA in porocarcinoma 174
Atypical Spitz tumors in patients younger than 18 years 173
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 171
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium 170
Analysis of protease-activated receptor-1 and -2 in human scar formation. 168
Characterization of regulatory T cells in patients with dermatomyositis. 167
In-vivo tissue imaging using a compact mobile nonlinear microscope 166
An Upgrade of Apparatus and Measurement Systems for Generation of Gaseous Formaldehyde: A Review 164
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors. 163
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: A pilot study. 163
Clinical and dermoscopic features of lichenoid keratosis: A retrospective case study 163
Preoperative evaluation of tumor ploidy in endometrial cancer: an accurate tool to identify patients at risk for extrauterine disease and recurrence. 162
Primary Orbital Synovial Sarcoma Mimicking a Periocular Cyst 162
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis 162
A blue-LED-based device for selective photocoagulation of superficial abrasions: theoretical modeling and in vivo validation 161
The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo 161
Circulating Tumor Cells Detection and Counting in Uveal Melanomas by a Filtration-Based Method 161
Diagnostic significance of blue hue in dermoscopy of melanocytic lesions: A dermoscopic-pathologic study. 160
Melanoma of the penis: a clinical dermoscopic case study. 160
Kaposi Sarcoma in a patient treated with Ruxolitinib 160
Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells. 160
GIANT PELVIC RETROPERITONEAL LIPOSARCOMA 159
Mutational concordance between primary and metastatic melanoma: A next-generation sequencing approach 159
Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge 159
Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression 158
A further case of subacute prurigo-like linear IgA bullous dermatosis: growing evidence of a new subset. 158
Multimodal fiber probe spectroscopy for tissue diagnostics applications: a combined Raman-fluorescence approachBiomedical Vibrational Spectroscopy VI: Advances in Research and Industry 156
Ntrk gene fusion detection in atypical spitz tumors 156
Improved label-free diagnostics and pathological assessment of atherosclerotic plaques through nonlinear microscopy 155
Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. 155
CDX-2 homeobox gene expression. 154
A ribonuclease protection assay-based approach for analysis of angiogenic gene expression in archival tissues. 154
An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma 154
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 153
CUTANEOUS MELANOMA HISTOLOGICALLY ASSOCIATED WITH A NEVUS AND MELANOMA DE NOVO HAVE A DIFFERENT PROFILE OF RISK. RESULTS FROM A CASE-CONTROL STUDY 153
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs 152
DERMOSCOPY IMPROVES ACCURACY OF PRIMARY CARE PHYSICIANS TO TRIAGE LESIONS SUGGESTIVE OF SKIN CANCER. 152
A new concept of melanocytic neoplasia pathogenesis based on the phenotype of common acquired nevi 152
Combined fluorescence-Raman spectroscopic setup for the diagnosis of melanocytic lesions 152
A particularly bothersome umbilical nodule. 152
Teledermoscopy in doubtful melanocytic lesions: is it really useful? 152
Acquired pseudoclubbing of a fingernail caused by spontaneous subungual haemangioma 151
Hyperplastic oral candidiasis of the tongue. 151
Seborrheic keratosis of the vulva clinically mimicking a genital wart: a case study. 151
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 151
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. 150
Totale 20.653
Categoria #
all - tutte 160.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.950 0 0 0 0 239 516 173 404 394 614 243 367
2021/20222.720 113 231 230 99 134 140 116 197 159 120 445 736
2022/20236.953 682 1.306 251 515 576 1.318 825 357 722 61 184 156
2023/20243.012 111 318 452 151 156 375 179 557 119 241 201 152
2024/202517.246 676 1.923 1.171 2.644 4.646 1.978 336 929 998 506 714 725
2025/20269.513 2.133 3.029 1.943 1.751 657 0 0 0 0 0 0 0
Totale 57.906